Continuity of Care Between Dyslipidemia Patients and Multiple Providers: A Cohort Study

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2024 May 2

PMID 38696494

Authors

Eunyoung Choi

JuHee Lee

Eunjung Choo

Eun Jin Jang

Iyn-Hyang Lee

Affiliations

Soon will be listed here.

Abstract

Objective: This study aimed to investigate the impacts of continuity of care (COC) between patients and multiple providers, i.e., doctors and community pharmacists, on clinical and economic outcomes.

Methods: This is a retrospective cohort study and analyzed Korean national claims data for ambulatory care setting between 2007 and 2018. Patients with dyslipidemia newly diagnosed in 2008 were identified. COC between providers and patients was computed using the continuity of care index (COCI). Based on COCIs, the study patients were allocated to four groups: HM/HP, HM/LP, LM/HP, and LM/LP. Each symbol represents H for high, L for low, M for doctor, and P for pharmacist. The primary study outcome was the incidence of atherosclerotic cardiovascular disease (ASCVD).

Results: 126,710 patients were included. Percentages of patients in the four study groups were as follows: HM/HP 35%, HM/LP 19%, LM/HP 12%, and LM/LP 34%. During the seven-year outcome period, 8,337 patients (6.6%) developed an ASCVD, and percentages in the study groups were as follows; HM/HP 6.2%, HM/LP 6.3%, LM/HP 6.8%, and LM/LP 7.1%. After adjusting for confounding covariates, only the LM/LP group had a significantly higher risk of ASCVD than the reference group, HM/HP (aHR = 1.16 [95% confidence interval = 1.10~1.22]). The risk of inappropriate medication adherence gradually increased 1.03-fold in the HM/LP group, 1.67-fold in the LM/HP, and 2.26-fold in the LM/LP group versus the HM/HP group after adjusting for covariates. Disease-related costs were lower in the HM/HP and LM/HP groups.

Conclusions: The study shows that patients with high relational care continuity with doctors and pharmacists achieved better clinical results and utilized health care less, resulting in reduced expenses. Further exploration for the group that exhibits an ongoing relationship solely with pharmacists is warranted.

References

Chong C, Campbell D, Elliott M, Aghajafari F, Ronksley P . Determining the Association Between Continuity of Primary Care and Acute Care Use in Chronic Kidney Disease: A Retrospective Cohort Study. Ann Fam Med. 2022; 20(3):237-245. PMC: 9199056. DOI: 10.1370/afm.2813. View

von Elm E, Altman D, Egger M, Pocock S, Gotzsche P, Vandenbroucke J . Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ. 2007; 335(7624):806-8. PMC: 2034723. DOI: 10.1136/bmj.39335.541782.AD. View

Tarn D, Pletcher M, Tosqui R, Fernandez A, Tseng C, Moriconi R . Primary nonadherence to statin medications: Survey of patient perspectives. Prev Med Rep. 2021; 22:101357. PMC: 8020471. DOI: 10.1016/j.pmedr.2021.101357. View

Arnett D, Blumenthal R, Albert M, Buroker A, Goldberger Z, Hahn E . 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019; 140(11):e563-e595. PMC: 8351755. DOI: 10.1161/CIR.0000000000000677. View

Stone N, Robinson J, Lichtenstein A, Merz C, Blum C, Eckel R . 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2013; 129(25 Suppl 2):S1-45. DOI: 10.1161/01.cir.0000437738.63853.7a. View

van Walraven C, Oake N, Jennings A, Forster A . The association between continuity of care and outcomes: a systematic and critical review. J Eval Clin Pract. 2010; 16(5):947-56. DOI: 10.1111/j.1365-2753.2009.01235.x. View

Mach F, Baigent C, Catapano A, Koskinas K, Casula M, Badimon L . 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2019; 41(1):111-188. DOI: 10.1093/eurheartj/ehz455. View

Lemstra M, Nwankwo C, Bird Y, Moraros J . Primary nonadherence to chronic disease medications: a meta-analysis. Patient Prefer Adherence. 2018; 12:721-731. PMC: 5944464. DOI: 10.2147/PPA.S161151. View

Lytsy P, Engstrom S, Ekstedt M, Engstrom I, Hansson L, Ali L . Outcomes associated with higher relational continuity in the treatment of persons with asthma or chronic obstructive pulmonary disease: A systematic review. EClinicalMedicine. 2022; 49:101492. PMC: 9167848. DOI: 10.1016/j.eclinm.2022.101492. View

10.

Lee J, Choi E, Choo E, Linda S, Jang E, Lee I . Relationship between continuity of care and clinical outcomes in patients with dyslipidemia in Korea: a real world claims database study. Sci Rep. 2022; 12(1):3062. PMC: 8866465. DOI: 10.1038/s41598-022-06973-3. View

11.

Choo E, Choi E, Lee J, Siachalinga L, Jang E, Lee I . Assessment of the effects of methodological choice in continuity of care research: a real-world example with dyslipidaemia cohort. BMJ Open. 2022; 11(12):e053140. PMC: 8719189. DOI: 10.1136/bmjopen-2021-053140. View

12.

Kim H, Kim S, Han S, Rane P, Fox K, Qian Y . Prevalence and incidence of atherosclerotic cardiovascular disease and its risk factors in Korea: a nationwide population-based study. BMC Public Health. 2019; 19(1):1112. PMC: 6694551. DOI: 10.1186/s12889-019-7439-0. View

13.

Liu T, Zhao D, Qi Y . Global Trends in the Epidemiology and Management of Dyslipidemia. J Clin Med. 2022; 11(21). PMC: 9656679. DOI: 10.3390/jcm11216377. View

14.

Hussey P, Schneider E, Rudin R, Fox D, Lai J, Pollack C . Continuity and the costs of care for chronic disease. JAMA Intern Med. 2014; 174(5):742-8. PMC: 4075052. DOI: 10.1001/jamainternmed.2014.245. View

15.

Jellinger P, Handelsman Y, Rosenblit P, Bloomgarden Z, Fonseca V, Garber A . AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE. Endocr Pract. 2017; 23(Suppl 2):1-87. DOI: 10.4158/EP171764.APPGL. View

16.

Fu M . Real-time detection and management of chronic illnesses. Mhealth. 2021; 7:1. PMC: 7882261. DOI: 10.21037/mhealth-2020-2. View

17.

Sikka R, Xia F, Aubert R . Estimating medication persistency using administrative claims data. Am J Manag Care. 2005; 11(7):449-57. View

18.

Bice T, Boxerman S . A quantitative measure of continuity of care. Med Care. 1977; 15(4):347-9. DOI: 10.1097/00005650-197704000-00010. View

19.

Kohnke H, Zielinski A . Association between continuity of care in Swedish primary care and emergency services utilisation: a population-based cross-sectional study. Scand J Prim Health Care. 2017; 35(2):113-119. PMC: 5499310. DOI: 10.1080/02813432.2017.1333303. View

20.

Chisholm-Burns M, Graff Zivin J, Lee J, Spivey C, Slack M, Herrier R . Economic effects of pharmacists on health outcomes in the United States: A systematic review. Am J Health Syst Pharm. 2010; 67(19):1624-34. DOI: 10.2146/ajhp100077. View